Evidence map›Paper›PMID 34837574›Full record

ArticleInternational urology and nephrology2022

Pre-surgical chronic kidney disease continues to drive outcomes in the modern era of minimally invasive renal surgery, despite advances in technology.

Danly Omil-Lima, Karishma Gupta, Ilon Weinstein, Mercedes Kent, Jonathan Shoag, David Sheyn, Irma Lengu

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Danly Omil-Lima *Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside Building Suite 4954, Cleveland, OH, 44106, USA. Danly.Omil-Lima@UHHospitals.org.ORCID http://orcid.org/0000-0002-6171-0116
Karishma Gupta *Urology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside Building Suite 4954, Cleveland, OH, 44106, USA.
Ilon WeinsteinCase Western Reserve University School of Medicine, Cleveland, OH, USA.
Mercedes KentUrology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside Building Suite 4954, Cleveland, OH, 44106, USA.
Jonathan ShoagUrology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside Building Suite 4954, Cleveland, OH, 44106, USA.
David SheynUrology Institute, University Hospitals Cleveland Medical Center, 11100 Euclid Avenue, Lakeside Building Suite 4954, Cleveland, OH, 44106, USA.
Irma LenguDivision of Urology, The MetroHealth System, Cleveland, OH, USA.
University Hospitals of Cleveland · USLake Erie College of Osteopathic Medicine · USMetroHealth · USNewYork–Presbyterian Hospital · USUniversity School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the impact of preoperative chronic kidney disease (CKD) on perioperative morbidity and mortality in a contemporary cohort undergoing renal surgery in an era of increased prevalence of minimally invasive surgery and partial nephrectomy.

methodsThe National Surgery Quality Improvement Program dataset was queried to identify patients undergoing radical nephrectomy (RN) or partial nephrectomy (PN) between 2010 and 2018. CKD staging was assigned based on creatinine clearance calculated using the Cockcroft-Gault formula. Multivariable logistic regression was performed to assess the effect of preoperative CKD stage on postoperative outcomes, including a composite variable encompassing multiple major complications.

resultsWe analyzed 19,545 patients with CKD undergoing renal surgery. CKD stage ≥ 2 predicted an increase in major perioperative complications, OR 1.54 (95% CI 1.46-1.63); p < 0.01. The risk of perioperative morbidity increased linearly with increasing CKD stage. Patients with CKD stage > 2 also demonstrated increased 30-day mortality, OR 1.87 (95% CI 1.26-2.48); p < 0.01. Adjusting for surgery type, CKD staging predicted perioperative mortality in patients undergoing RN only, and perioperative morbidity in RN and PN.

conclusionsHere, we demonstrate a statistically significant increase in the risk of major postoperative complications following RN and PN with increasing CKD stage. Amongst patients undergoing RN, we also demonstrate increasing 30-day mortality with increasing CKD stage. Importantly, we highlight the ability of CKD staging to predict major perioperative outcomes with greater magnitude of effect than surgery type alone. Thus, we provide a model for translating CKD staging into operative risk amongst patients undergoing surgery for a renal mass.

Indexed as

Cohort StudiesCross-Sectional StudiesHumansKidney NeoplasmsMinimally Invasive Surgical ProceduresNephrectomyPostoperative ComplicationsPreoperative PeriodRenal Insufficiency, ChronicRetrospective StudiesTreatment OutcomeChronic kidney diseasePartial nephrectomyRadical nephrectomyRisk stratificationSurgical outcomes

Identifiers

PMID34837574
OpenAlexW3216246685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.